- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Tobacco and Consumer Products Trials
News 9 results
Cases & Deals
January 15, 2021
R.J. Reynolds Obtains Reversal of $15.5M Judgment
Press Release
January 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
Recognition
December 17, 2020
Law360 Names King & Spalding a Product Liability Practice Group of the Year
Cases & Deals
October 26, 2020
K&S Represents Group of Cannabis Growers in Lawsuit Against Trinity County, CA
Recognition
October 22, 2019
National Black Lawyers Names TaCara Harris to its “Top 40 Under 40” List
Cases & Deals
August 28, 2019
R.J. Reynolds Has $42 Million Judgment Reversed
Cases & Deals
April 5, 2019
King & Spalding Team Achieves Defense Verdict in Johnson & Johnson Talcum Powder Trial
Recognition
February 11, 2019
Law360 Names King & Spalding’s Product Liability Practice a 2018 Practice Group of the Year for Sixth Straight Year
Cases & Deals
December 12, 2018
King & Spalding Client RJ Reynolds Obtains Appellate Victory on Punitive Damages in Florida